Physician profile
Samuel Shine
NPI 1124656921
$8,486.63
in general payments reported to CMS, 2019-2025
8 companies · $4,471 in 2025
The $4,471 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.03 · 2021: $24.04 · 2022: $1,285 · 2023: $916 · 2024: $1,772 · 2025: $4,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,255 · Travel and Lodging: $2,215 · Education: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,255.16 |
| Travel and Lodging | $2,215.44 |
| Education | $688.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,484.03 | 2023-2025 | Pro, Pangea, T2 Alpha |
| Cdc Medical LLC | $1,220.80 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $1,165.26 | 2023-2025 | Persona, Rosa, Tapestry |
| Depuy Synthes Sales INC. | $346.81 | 2024-2025 | Lcp, Tfn-Advance, Na |
| Cerapedics INC. | $105.60 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Kci USA, INC. | $84.91 | 2022 | |
| Avanos Medical | $43.07 | 2020-2021 | |
| Legacy Ortho LLC | $36.15 | 2024-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Shine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.